Market Cap 11.97B
Revenue (ttm) 393.50M
Net Income (ttm) -409.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -103.97%
Debt to Equity Ratio -4.23
Volume 227,300
Avg Vol 477,784
Day's Range N/A - N/A
Shares Out 61.21M
Stochastic %K 16%
Beta 0.39
Analysts Strong Sell
Price Target $251.56

Company Profile

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candid...

Industry: Biotechnology
Sector: Healthcare
Phone: 45 70 22 22 44
Address:
Tuborg Boulevard 12, Hellerup, Denmark
CaptainAmrica
CaptainAmrica Sep. 10 at 8:10 PM
I think we have 2 or 3 more weeks of down bias drift in the market then the rally fueled by tech, data and ai...Sold CRCL, APLD BMNR CRWV CWVX today...Rebought CRCL small amount ....Bullish on $GLXY.... Bot more $HON, $ASND, $CRSP...
0 · Reply
dogDazeSummer
dogDazeSummer Sep. 8 at 6:19 PM
$ASND Congrats on making yet another ATH! Always wonder if Ascendis will someday be part of $ABBV What a run from $17. RA Capital biggest holding: Ascendis 10,281,496 shares valued at $2B RA Capital Smallest & newest holding added last 13F 8/15/25 for Q2: Inflarx $IFRX 1,973,233 shares valued at $3M
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Sep. 7 at 10:53 AM
$ASND beast
0 · Reply
Pika_Capital
Pika_Capital Sep. 5 at 7:11 PM
$ASND top position at the moment. She keeps running.
1 · Reply
WAJeff
WAJeff Sep. 5 at 4:53 PM
0 · Reply
StockConsultant
StockConsultant Sep. 3 at 12:21 PM
$ASND Ascendis Pharma stock, narrow range breakout
0 · Reply
JFDI
JFDI Sep. 2 at 7:29 PM
$ASND 200 b/o
0 · Reply
WAJeff
WAJeff Sep. 2 at 7:11 PM
$ASND $203.59 ath
0 · Reply
QuantTheta
QuantTheta Sep. 2 at 5:18 PM
$ASND out of squeeze
0 · Reply
JarvisFlow
JarvisFlow Sep. 2 at 4:34 PM
JP Morgan has updated their rating for Ascendis Pharma ( $ASND ) to Overweight with a price target of 165.
0 · Reply
Latest News on ASND
Ascendis Pharma A/S (ASND) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 2:46 AM EDT - 5 weeks ago

Ascendis Pharma A/S (ASND) Q2 2025 Earnings Call Transcript


Ascendis Pharma Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:01 PM EDT - 5 weeks ago

Ascendis Pharma Reports Second Quarter 2025 Financial Results


FDA Accepts TransCon® CNP NDA for Priority Review

Jun 2, 2025, 8:00 AM EDT - 3 months ago

FDA Accepts TransCon® CNP NDA for Priority Review


Ascendis Pharma A/S (ASND) Q1 2025 Earnings Call Transcript

May 1, 2025, 9:35 PM EDT - 4 months ago

Ascendis Pharma A/S (ASND) Q1 2025 Earnings Call Transcript


Ascendis Pharma Reports First Quarter 2025 Financial Results

May 1, 2025, 4:01 PM EDT - 4 months ago

Ascendis Pharma Reports First Quarter 2025 Financial Results


Ascendis Pharma A/S (ASND) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 11:03 PM EST - 7 months ago

Ascendis Pharma A/S (ASND) Q4 2024 Earnings Call Transcript


Ascendis Pharma: Danish Blockbuster Hunter

Jan 29, 2025, 12:31 AM EST - 8 months ago

Ascendis Pharma: Danish Blockbuster Hunter


Ascendis Pharma A/S (ASND) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 10:53 PM EST - 10 months ago

Ascendis Pharma A/S (ASND) Q3 2024 Earnings Call Transcript


Ascendis Pharma Reports Third Quarter 2024 Financial Results

Nov 14, 2024, 4:01 PM EST - 10 months ago

Ascendis Pharma Reports Third Quarter 2024 Financial Results


Ascendis Pharma Takes A Big Price Cut On Skytrofa

Sep 5, 2024, 1:30 AM EDT - 1 year ago

Ascendis Pharma Takes A Big Price Cut On Skytrofa


Ascendis Pharma A/S (ASND) Q2 2024 Earnings Call Transcript

Sep 3, 2024, 9:41 PM EDT - 1 year ago

Ascendis Pharma A/S (ASND) Q2 2024 Earnings Call Transcript


CaptainAmrica
CaptainAmrica Sep. 10 at 8:10 PM
I think we have 2 or 3 more weeks of down bias drift in the market then the rally fueled by tech, data and ai...Sold CRCL, APLD BMNR CRWV CWVX today...Rebought CRCL small amount ....Bullish on $GLXY.... Bot more $HON, $ASND, $CRSP...
0 · Reply
dogDazeSummer
dogDazeSummer Sep. 8 at 6:19 PM
$ASND Congrats on making yet another ATH! Always wonder if Ascendis will someday be part of $ABBV What a run from $17. RA Capital biggest holding: Ascendis 10,281,496 shares valued at $2B RA Capital Smallest & newest holding added last 13F 8/15/25 for Q2: Inflarx $IFRX 1,973,233 shares valued at $3M
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Sep. 7 at 10:53 AM
$ASND beast
0 · Reply
Pika_Capital
Pika_Capital Sep. 5 at 7:11 PM
$ASND top position at the moment. She keeps running.
1 · Reply
WAJeff
WAJeff Sep. 5 at 4:53 PM
0 · Reply
StockConsultant
StockConsultant Sep. 3 at 12:21 PM
$ASND Ascendis Pharma stock, narrow range breakout
0 · Reply
JFDI
JFDI Sep. 2 at 7:29 PM
$ASND 200 b/o
0 · Reply
WAJeff
WAJeff Sep. 2 at 7:11 PM
$ASND $203.59 ath
0 · Reply
QuantTheta
QuantTheta Sep. 2 at 5:18 PM
$ASND out of squeeze
0 · Reply
JarvisFlow
JarvisFlow Sep. 2 at 4:34 PM
JP Morgan has updated their rating for Ascendis Pharma ( $ASND ) to Overweight with a price target of 165.
0 · Reply
Pika_Capital
Pika_Capital Sep. 2 at 2:17 PM
$ASND let's go boys. All time highs
0 · Reply
Estimize
Estimize Sep. 1 at 11:06 AM
Wall St is expecting -0.31 EPS for $ASND Q3 [Reporting 11/13 AMC] http://www.estimize.com/intro/asnd?chart=historical&metric_name=eps&utm_c
0 · Reply
dogDazeSummer
dogDazeSummer Aug. 27 at 4:21 PM
$IFRX RA involvement greatly overlooked. Of the 63 stocks in the RA portfolio —-the biggest holding as a % of total portfolio is $ASND at 29.89% or $1.7b staring in 2015 at $17/ share. Yes they average up. The smallest holding as a % of the total portfolio is Inflarx .0262% or $1.6m The average of 63 holdings is $94M Many of the 63 holdings represent 10%+ of outstanding shares. They don’t buy small companies unless they expect big things. https://www.racap.com/faq Q: When deciding how much to invest, we focus on whether the return *is likely to be impactful for our fund.* “That means that we might invest a small amount in a very small company, maybe even under $1M in a seed round, or a larger amount in a large company that we think has a lot of upside (we have invested as much as $75M in a single round). But we are unlikely to invest a small amount in a large company (e.g. $5M in a $500M to own 1%) unless it’s just the first step towards establishing greater ownership”.
3 · Reply
tymtested
tymtested Aug. 23 at 3:59 PM
$ASND is this Denmark company still reporting huge quarterly losses??
2 · Reply
AP530
AP530 Aug. 20 at 2:03 PM
$ASND surprised this hasn’t hit over $200 yet. Was so close too
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Aug. 16 at 4:14 PM
1 · Reply
JFDI
JFDI Aug. 14 at 3:42 PM
$ASND ABCD
0 · Reply
pugmarkettt
pugmarkettt Aug. 13 at 3:17 PM
$ASND ascend Deez nuts already
0 · Reply
Pika_Capital
Pika_Capital Aug. 12 at 6:39 PM
$ASND you can NOT stop $200 from coming. Let's go baby!!
1 · Reply
Doozio
Doozio Aug. 10 at 6:02 PM
$GILD it was always during 🐒🍌🧠⏰♾️ wen da huckleberries would $ASND thru the $$$$ as 🧠leader🐑 is becoming obviously obvious. 🐑 $XBI shall follow.
0 · Reply
JarvisFlow
JarvisFlow Aug. 8 at 11:00 PM
Citigroup has updated their rating for Ascendis Pharma ( $ASND ) to Buy with a price target of 290.
0 · Reply
Pika_Capital
Pika_Capital Aug. 8 at 5:04 PM
$ASND can't believe I snatched some shares at $179 today 😂
2 · Reply